Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin

BACKGROUND: Simeprevir with peginterferon and ribavirin has been used for the treatment of chronic hepatitis caused by genotype 1 hepatitis C virus (HCV). We explored the predictive factors for sustained virological response (SVR) and viral relapse using datasets from four Japanese phase 3 studies (...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepatol Int
Egile Nagusiak: Nakayama, Masahiko, Kobayashi, Hisanori, Fukushima, Koji, Ishido, Miwako, Komada, Yuji, Yoshizawa, Kazutake
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer India 2015
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4722076/
https://ncbi.nlm.nih.gov/pubmed/26264253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-015-9654-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak